Novavax Completes Enrolling 30,000 People in US Trial of COVID-19 Vaccine

(Reuters) – Drug developer Novavax Inc said on Monday it has completed enrolling 30,000 volunteers in a late-stage study of its COVID-19 vaccine in the United States and Mexico. The company said last month its vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, […]

Adverse Mental Health Symptoms Related to COVID-19 Remained High 6 Months Into Pandemic

(Reuters Health) – As of September 2020, the prevalence of adverse mental health symptoms remained high among Americans, a new survey finds. Rates of suicidal ideation, substance abuse, and symptoms of depression and anxiety in August and September were elevated above prepandemic estimates, especially among survey participants under age 65, […]

GSK, Vir Biotech to Expand COVID-19 Research Partnership for Other Diseases

(Reuters) – British drugmaker GlaxoSmithKline Plc and Vir Biotechnology Inc will expand their existing partnership developing antibody therapies for COVID-19 to research therapies for other diseases, the companies said on Wednesday. The companies will research monoclonal antibody treatments for influenza and other respiratory illnesses as a part of the agreement, […]

Most European countries ignore patients with severe mental illness in COVID-19 vaccine strategy

A survey by Europe’s main psychiatric and mental health patient organizations shows that only 4 out of 20 European countries prioritize COVID vaccinations for individuals with severe mental disorders (such as psychosis and mood problems), despite a wealth of scientific evidence showing that these patients are amongst the most at […]